This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Zilosul

Paradigm Biopharmaceuticals

Drug Names(s): PPS, Pentosan Polysulphate Sodium

Deal Structure: Pentosan polysulphate sodium or PPS is a heterogeneous semi-synthetic drug manufactured from European beech-wood hemicellulose by sulphate esterification. Its primary use over the last 60 years in Europe has been for the treatment and prevention of blood clots.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug